Welcome!

News Feed Item

Moleac Appoints Elmar Schnee as Non-Executive Chairman

SINGAPORE, April 28, 2014 /PRNewswire/ -- Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive Chairman of the company.

Elmar Schnee succeeds to Prof Marc Vasseur, co-founder of Moleac and first Chairman (2004-2013).

Mr. Schnee was from 2011 - 2013 CEO of Cardiorentis in Zug, Switzerland. Prior to this, Mr. Schnee was General Partner and member of the Executive Board of Merck KGaA, responsible for its worldwide pharmaceutical business in Rx and OTC with sales of € 6 Billion and 18,000 employees until June 2011. He also led the major restructuring of the business in acquiring Serono for € 10.3 billion and selling the Generic Division for € 4.9 billion. Mr. Schnee led the successful integration into Merck Serono as CEO until end of 2010.

Mr. Schnee joined Merck KGaA in 2003 as President for France.  He was promoted to Head of Global Ethical Pharmaceuticals and in 2005 elected as General Partner and Member of the Executive Board.

Prior Mr. Schnee held senior roles in Marketing, Strategy and Business Development in UCB Brussels, Sanofi-Synthelabo in Paris, Migliara Kaplan in Baltimore and Fisons in UK.

Mr. Schnee is currently a Director of Gentium SpA, Cardiorentis AG and Anecova SA.

Elmar Schnee said:

"I am very excited to join Moleac as Chairman and work together with the board and management to further develop NeuroAiD. Moleac has unique knowledge in the area of stroke recovery and NeuroAiD has proven already its utility in supporting stroke patients recovering faster and better. There is a great need for new drugs supporting stroke patients and I recognise the potential of Moleac to develop new drugs in this high need indication."

David Picard CEO of Moleac said:

"Moleac has provided already a therapeutic solution to thousands of stroke survivors with NeuroAiD.  It now aims to deliver a stroke treatment which will enable an even larger number of patients to benefit from its knowhow. We welcome the wide experience that Elmar brings to Moleac in pharmaceutical development and operations, to take Moleac through the second stage of its rapid development to answer the needs of the stroke sufferers."

About Moleac

Moleac is a biopharmaceutical company founded in 2003 in Singapore, dedicated in finding and developing new medicines for the unmet needs of patients worldwide. Its development model combines a modern clinical approach and the latest biotechnologies.

www.moleac.com

About NeuroAiD

NeuroAiD™ is the first stroke treatment that helps patients recover faster and a better from stroke disabilities while combined to a rehabilitation program. NeuroAiD™ is derived from natural components, carefully selected for their efficacy and safe use. It currently reaches out to patients in over 25 countries.

www.neuroaid.com

Contact:

For further information, please contact Olfa Khechine, Global Marketing Manager, Moleac Singapore

Tel: (+65) 6211 3710 - Ext. 124
Email: [email protected]

SOURCE Moleac

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"DivvyCloud as a company set out to help customers automate solutions to the most common cloud problems," noted Jeremy Snyder, VP of Business Development at DivvyCloud, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Michael Maximilien, better known as max or Dr. Max, is a computer scientist with IBM. At IBM Research Triangle Park, he was a principal engineer for the worldwide industry point-of-sale standard: JavaPOS. At IBM Research, some highlights include pioneering research on semantic Web services, mashups, and cloud computing, and platform-as-a-service. He joined the IBM Cloud Labs in 2014 and works closely with Pivotal Inc., to help make the Cloud Found the best PaaS.
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen...